The Australasian Journal of Dermatology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Immune checkpoint inhibitor-induced lichenoid drug eruption-sparing scar burns
Australas J Dermatol. 2023 Nov 27. doi: 10.1111/ajd.14192. Online ahead of print.ABSTRACTThe authors present a striking case of a patient experiencing a lichenoid drug eruption secondary to immunotherapy, curiously sparing scarred skin from past burns. We observed vastly higher amounts of inflammatory lymphoid cells staining for PD-1; 70% in skin with a lichenoid drug reaction and 50% in scarred skin. The lack of a lichenoid reaction at sites of scarred skin may indicate that a basement membrane component may be causative for a lichenoid drug eruption.PMID:38009870 | DOI:10.1111/ajd.14192 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - November 27, 2023 Category: Dermatology Authors: Kelvin Truong Charmaine Vanessa Chamberlin Jennifer Kim Matteo S Carlino Raquel Ruiz Araujo Source Type: research

Subcorneal pustular dermatosis induced by dupilumab: A novel case
Australas J Dermatol. 2023 Nov 27. doi: 10.1111/ajd.14190. Online ahead of print.NO ABSTRACTPMID:38009895 | DOI:10.1111/ajd.14190 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - November 27, 2023 Category: Dermatology Authors: Sasha Hall Christopher Y Chew Tom Kovitwanichkanont Ken Hiu-Kan Ip Jennifer Cahill Alexander Gin Catriona A McLean Douglas Gin Source Type: research

A rare entity: Progressive multisystem involvement in type 1 cryoglobulinaemia
Australas J Dermatol. 2023 Nov 24. doi: 10.1111/ajd.14191. Online ahead of print.NO ABSTRACTPMID:37997690 | DOI:10.1111/ajd.14191 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - November 24, 2023 Category: Dermatology Authors: Matthew J Verheyden Shirley P Yu Source Type: research

Diagnosis of cutaneous primary nocardiosis in patients with normal immune function by metagenomic next-generation sequencing
We report a case that was diagnosed with primary cutaneous Nocardia by metagenomic next-generation sequencing technology.PMID:37985465 | DOI:10.1111/ajd.14187 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - November 20, 2023 Category: Dermatology Authors: Yue Mou Jiaqi Liu Chaochao Ji Wenhao Cheng Hong Ren Xudong Mou Wenlong Hu Source Type: research

Management of primary plantar hyperhidrosis with botulinum toxin type A: A retrospective case series of 129 patients
CONCLUSIONS: The results of this retrospective study suggest that BoNT-A is an effective and safe treatment option for PPH.PMID:37964488 | DOI:10.1111/ajd.14188 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - November 15, 2023 Category: Dermatology Authors: Aikaterini Tsiogka Efthymia Agiasofitou Antonios Tsimpidakis George Kontochristopoulos Alexander Stratigos Stamatios Gregoriou Source Type: research

Methotrexate therapy for adult and paediatric moderate-to-severe atopic dermatitis: A PRISMA-compliant meta-analysis of data from daily practice
Australas J Dermatol. 2023 Nov 8. doi: 10.1111/ajd.14183. Online ahead of print.ABSTRACTOf the 15 eligible studies identified via electronic searches in MEDLINE, EMBASE and CENTRAL in November 2022 for methotrexate therapy of moderate-to-severe atopic dermatitis, 12 were non-randomized controlled trial (non-RCT) studies with data from 437 patients (235 adults and 202 children). The response rates for short-term therapy were 77% [95% CI 55-99] (four studies; adults) - comparable to 81% [54-100] of RCTs (two studies; adults) (p = 0.63) - and 61% [43-79] (two studies; children), and for medium/long-term therapy were 88.9% [74...
Source: The Australasian Journal of Dermatology - November 9, 2023 Category: Dermatology Authors: Qiaohong Wang Liheng Chen Source Type: research